Structure Therapeutics Inc. (GPCR)
NASDAQ·Healthcare·Biotechnology
$47.51
-0.80%
Mkt Cap $3.25B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (16 analysts)
$111.60
Range $70.00 – $145.00
Implied Upside
+134.9%
Consensus $111.60 vs current $47.51
NASDAQ·Healthcare·Biotechnology
$47.51
-0.80%
Mkt Cap $3.25B
Buy
3
Hold
0
Sell
0
Price Target (16 analysts)
$111.60
Range $70.00 – $145.00
+134.9%
Consensus $111.60 vs current $47.51